Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan
2018 ◽
Vol 48
(11-12)
◽
pp. 1290-1300
◽
2020 ◽
Vol 43
(8)
◽
pp. 418-425
2020 ◽
Vol 8
(3)
◽
pp. 1-14
2021 ◽
Drug–Drug Interactions of Newly Approved Direct-Acting Antiviral Agents in Patients with Hepatitis C
2021 ◽
Vol Volume 14
◽
pp. 289-301
2016 ◽
Vol 83
(2)
◽
pp. 269-293
◽